Clinical trials
Phase 2 Lung Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
137 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 5 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 10 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 7 |
| 2022 | 11 |
| 2023 | 10 |
| 2024 | 19 |
| 2025 | 19 |
| 2026 | 16 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 45 |
| Recruiting | 43 |
| Completed | 17 |
| Not yet recruiting | 15 |
| Active, not recruiting | 8 |
| Withdrawn | 6 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 15 |
| Shanghai Pulmonary Hospital, Shanghai, China | 6 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 5 |
| The First Affiliated Hospital of Guangzhou Medical University | 5 |
| Tianjin Medical University Cancer Institute and Hospital | 5 |
| AstraZeneca | 4 |
| Jiangsu HengRui Medicine Co., Ltd. | 4 |
| Zhejiang Cancer Hospital | 4 |
| Avistone Biotechnology Co., Ltd. | 3 |
| Pfizer | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 137 |
| Carcinoma, Non-Small-Cell Lung | 44 |
| Breast Neoplasms | 7 |
| Small Cell Lung Carcinoma | 7 |
| Adenocarcinoma of Lung | 5 |
| Neoplasms | 5 |
| Brain Neoplasms | 4 |
| Esophageal Neoplasms | 4 |
| Lung Diseases | 4 |
| Bronchial Neoplasms | 3 |
Trials
Showing 1 to 25 of 137. Each trial links to its page on Pharma Observatory.
37 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.